Renovaro Biosciences Inc.
(RENB)
undefined
undefined%
At close: undefined
1.71
-3.39%
After-hours Dec 13, 2024, 06:08 PM EST
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
PE Ratio | -0.47 | -0.20 | -0.22 | -2.19 | -4.27 | -2.32 | -2.89 | -8.44 | -8.10 |
PS Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 328.78 |
PB Ratio | 0.28 | 0.17 | 0.35 | 0.34 | 0.29 | 0.24 | 0.11 | 11.80 | -22.06 |
P/FCF Ratio | -3.40 | -0.68 | -1.61 | -2.84 | -4.58 | -4.54 | -4.17 | -15.37 | -9.55 |
P/OCF Ratio | -3.42 | -0.68 | -1.61 | -2.84 | -4.66 | -4.92 | -4.20 | -15.37 | -9.55 |
OCF/S Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -8.61 |
Debt / Equity Ratio | 0.00 | 0.03 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.34 | -0.04 |
Quick Ratio | 0.02 | 0.06 | 0.37 | 2.77 | 1.67 | 2.81 | 4.51 | 0.35 | 0.12 |
Current Ratio | 0.02 | 0.06 | 0.37 | 2.77 | 1.67 | 2.81 | 4.51 | 0.35 | 0.12 |
Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 |
Interest Coverage | -20.18 | -13.63 | -77.83 | -15.41 | -28.59 | -63895.52 | -5.65 | -22.85 | -224.29 |
Return on Equity (ROE) | -61.11% | -85.34% | -156.20% | -15.30% | -6.87% | -10.41% | -3.98% | -139.80% | 272.24% |
Return on Assets (ROA) | -49.44% | -68.07% | -134.03% | -14.09% | -6.41% | -10.02% | -3.46% | -47.39% | -199.26% |
Return on Capital (ROIC) | -61.47% | -81.55% | -148.47% | -12.47% | -6.75% | -6.15% | -1.78% | -156.61% | 332.75% |
Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.90% |
Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -1014.31% |